Perspectives of patients and healthcare professionals on metabolic monitoring of adult prescribed second-generation antipsychotics for severe mental illness: A meta-synthesis.

<h4>Objectives</h4>We conducted a meta-synthesis of qualitative studies to synthesize the views of psychiatric patients on second-generation antipsychotics (SGAs) and the healthcare providers about the metabolic monitoring of adult-prescribed SGAs.<h4>Methods</h4>A systematic...

Full description

Bibliographic Details
Main Authors: Pooja Gopal Poojari, Sohil Khan, Sonia Shenoy, Sahana Shetty, Keshava Pai, Leelavathi D Acharya, Swarnali Bose, Girish Thunga
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0283317
_version_ 1797829918673862656
author Pooja Gopal Poojari
Sohil Khan
Sonia Shenoy
Sahana Shetty
Keshava Pai
Leelavathi D Acharya
Swarnali Bose
Girish Thunga
author_facet Pooja Gopal Poojari
Sohil Khan
Sonia Shenoy
Sahana Shetty
Keshava Pai
Leelavathi D Acharya
Swarnali Bose
Girish Thunga
author_sort Pooja Gopal Poojari
collection DOAJ
description <h4>Objectives</h4>We conducted a meta-synthesis of qualitative studies to synthesize the views of psychiatric patients on second-generation antipsychotics (SGAs) and the healthcare providers about the metabolic monitoring of adult-prescribed SGAs.<h4>Methods</h4>A systematic search was conducted in four databases through SCOPUS, PubMed, EMBASE, and CINAHL to identify qualitative studies of patients' and healthcare professionals' perspectives on the metabolic monitoring of SGAs. Initially, titles and abstracts were screened to exclude articles that were not relevant followed by full-text reading. Study quality was assessed by using Critical Appraisal Skills Program (CASP) criteria. Themes were synthesized and presented as per the Interpretive data synthesis process (Evans D, 2002).<h4>Results</h4>A total of 15 studies met the inclusion criteria and were analyzed in meta-synthesis. Four themes were identified: 1. Barriers to metabolic monitoring; 2. Patient related concerns to metabolic monitoring; 3. Support system by mental health services to promote metabolic monitoring; and 4. Integrating physical health with mental health services. From the participants' perspectives, barriers to metabolic monitoring were accessibility of services, lack of education and awareness, time/resource constraints, financial hardship, lack of interest on metabolic monitoring, patient capacity and motivation to maintain physical health and role confusion and impact on communication. Education and training on monitoring practices as well as integrated mental health services for metabolic monitoring to promote quality and safe use of SGAs are the most likely approaches to promote adherence to best practices and minimize treatment-related metabolic syndrome in this highly vulnerable cohort.<h4>Conclusion</h4>This meta-synthesis highlights key barriers from the perspectives of patients and healthcare professionals regarding the metabolic monitoring of SGAs. These barriers and suggested remedial strategies are important to pilot in the clinical setting and to assess the impact of the implementation of such strategies as a component of pharmacovigilance to promote the quality use of SGAs as well as to prevent and/or manage SGAs-induced metabolic syndrome in severe and complex mental health disorders.
first_indexed 2024-04-09T13:27:50Z
format Article
id doaj.art-c3607f67a9df487aa28e41aa51612f0b
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-09T13:27:50Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-c3607f67a9df487aa28e41aa51612f0b2023-05-10T05:32:09ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01184e028331710.1371/journal.pone.0283317Perspectives of patients and healthcare professionals on metabolic monitoring of adult prescribed second-generation antipsychotics for severe mental illness: A meta-synthesis.Pooja Gopal PoojariSohil KhanSonia ShenoySahana ShettyKeshava PaiLeelavathi D AcharyaSwarnali BoseGirish Thunga<h4>Objectives</h4>We conducted a meta-synthesis of qualitative studies to synthesize the views of psychiatric patients on second-generation antipsychotics (SGAs) and the healthcare providers about the metabolic monitoring of adult-prescribed SGAs.<h4>Methods</h4>A systematic search was conducted in four databases through SCOPUS, PubMed, EMBASE, and CINAHL to identify qualitative studies of patients' and healthcare professionals' perspectives on the metabolic monitoring of SGAs. Initially, titles and abstracts were screened to exclude articles that were not relevant followed by full-text reading. Study quality was assessed by using Critical Appraisal Skills Program (CASP) criteria. Themes were synthesized and presented as per the Interpretive data synthesis process (Evans D, 2002).<h4>Results</h4>A total of 15 studies met the inclusion criteria and were analyzed in meta-synthesis. Four themes were identified: 1. Barriers to metabolic monitoring; 2. Patient related concerns to metabolic monitoring; 3. Support system by mental health services to promote metabolic monitoring; and 4. Integrating physical health with mental health services. From the participants' perspectives, barriers to metabolic monitoring were accessibility of services, lack of education and awareness, time/resource constraints, financial hardship, lack of interest on metabolic monitoring, patient capacity and motivation to maintain physical health and role confusion and impact on communication. Education and training on monitoring practices as well as integrated mental health services for metabolic monitoring to promote quality and safe use of SGAs are the most likely approaches to promote adherence to best practices and minimize treatment-related metabolic syndrome in this highly vulnerable cohort.<h4>Conclusion</h4>This meta-synthesis highlights key barriers from the perspectives of patients and healthcare professionals regarding the metabolic monitoring of SGAs. These barriers and suggested remedial strategies are important to pilot in the clinical setting and to assess the impact of the implementation of such strategies as a component of pharmacovigilance to promote the quality use of SGAs as well as to prevent and/or manage SGAs-induced metabolic syndrome in severe and complex mental health disorders.https://doi.org/10.1371/journal.pone.0283317
spellingShingle Pooja Gopal Poojari
Sohil Khan
Sonia Shenoy
Sahana Shetty
Keshava Pai
Leelavathi D Acharya
Swarnali Bose
Girish Thunga
Perspectives of patients and healthcare professionals on metabolic monitoring of adult prescribed second-generation antipsychotics for severe mental illness: A meta-synthesis.
PLoS ONE
title Perspectives of patients and healthcare professionals on metabolic monitoring of adult prescribed second-generation antipsychotics for severe mental illness: A meta-synthesis.
title_full Perspectives of patients and healthcare professionals on metabolic monitoring of adult prescribed second-generation antipsychotics for severe mental illness: A meta-synthesis.
title_fullStr Perspectives of patients and healthcare professionals on metabolic monitoring of adult prescribed second-generation antipsychotics for severe mental illness: A meta-synthesis.
title_full_unstemmed Perspectives of patients and healthcare professionals on metabolic monitoring of adult prescribed second-generation antipsychotics for severe mental illness: A meta-synthesis.
title_short Perspectives of patients and healthcare professionals on metabolic monitoring of adult prescribed second-generation antipsychotics for severe mental illness: A meta-synthesis.
title_sort perspectives of patients and healthcare professionals on metabolic monitoring of adult prescribed second generation antipsychotics for severe mental illness a meta synthesis
url https://doi.org/10.1371/journal.pone.0283317
work_keys_str_mv AT poojagopalpoojari perspectivesofpatientsandhealthcareprofessionalsonmetabolicmonitoringofadultprescribedsecondgenerationantipsychoticsforseverementalillnessametasynthesis
AT sohilkhan perspectivesofpatientsandhealthcareprofessionalsonmetabolicmonitoringofadultprescribedsecondgenerationantipsychoticsforseverementalillnessametasynthesis
AT soniashenoy perspectivesofpatientsandhealthcareprofessionalsonmetabolicmonitoringofadultprescribedsecondgenerationantipsychoticsforseverementalillnessametasynthesis
AT sahanashetty perspectivesofpatientsandhealthcareprofessionalsonmetabolicmonitoringofadultprescribedsecondgenerationantipsychoticsforseverementalillnessametasynthesis
AT keshavapai perspectivesofpatientsandhealthcareprofessionalsonmetabolicmonitoringofadultprescribedsecondgenerationantipsychoticsforseverementalillnessametasynthesis
AT leelavathidacharya perspectivesofpatientsandhealthcareprofessionalsonmetabolicmonitoringofadultprescribedsecondgenerationantipsychoticsforseverementalillnessametasynthesis
AT swarnalibose perspectivesofpatientsandhealthcareprofessionalsonmetabolicmonitoringofadultprescribedsecondgenerationantipsychoticsforseverementalillnessametasynthesis
AT girishthunga perspectivesofpatientsandhealthcareprofessionalsonmetabolicmonitoringofadultprescribedsecondgenerationantipsychoticsforseverementalillnessametasynthesis